Related references
Note: Only part of the references are listed.E-cadherin and hereditary diffuse gastric cancer
Corrado Pedrazzani et al.
SURGERY (2007)
Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models
Kaori Fujimoto-Ouchi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus
Uta Reichelt et al.
MODERN PATHOLOGY (2007)
HER-2/neu amplification is an independent prognostic factor in gastric cancer
Dong Il Park et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Chemotherapy in advanced gastric cancer: A systematic review and meta-analysis based on aggregate data
Anna D. Wagner et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Amplification of HER-2 in gastric carcinoma:: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab
M Tanner et al.
ANNALS OF ONCOLOGY (2005)
Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches
M Scartozzi et al.
CANCER TREATMENT REVIEWS (2004)
Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer
I García et al.
ANNALS OF SURGICAL ONCOLOGY (2003)
Status of c-erbB-2 in gastric adenocarcinoma:: A comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay
T Takehana et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
JS Macdonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Her-2/neu and breast cancer
S Kaptain et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2001)
Protein overexpression and gene amplification of c-erb B-2 in pulmonary carcinomas:: A comparative immunohistochemical and fluorescence in situ hybridization study
N Hirashima et al.
MODERN PATHOLOGY (2001)
Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: A follow-up study based on 138 cases from a diagnostic variability study
E Montgomery et al.
HUMAN PATHOLOGY (2001)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Breast cancer in the 21st century: Neu opportunities and neu challenges
SJ Schnitt
MODERN PATHOLOGY (2001)
The use of molecular biology in diagnosis and prognosis of gastric cancer
KF Becker et al.
SURGICAL ONCOLOGY-OXFORD (2000)
Analysis of 154 actual five-year survivors of gastric cancer
SN Hochwald et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2000)
Share Paper
